Skip to main content

Dementia, Delirium, and Depression

  • Chapter
  • First Online:
Geriatric Urology
  • 1191 Accesses

Abstract

Concern about an older adult’s cognitive function is common, so any clinician involved in the care of older adults needs to be familiar with conditions which can affect cognitive function. Dementia, delirium, and depression can all cause memory loss and confusion, and all three conditions have different presentations and treatments. This chapter reviews the etiology, clinical evaluation and treatment options for dementia, delirium and depression in geriatric patients, and the relationship of these conditions to urologic healthcare for older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res. 1975;12:189–98.

    Article  CAS  PubMed  Google Scholar 

  2. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The Mini-Cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.

    Article  CAS  PubMed  Google Scholar 

  3. Takao H, Hayashi N, Ohtomo K. A longitudinal study of brain volume changes in normal aging. Eur J Radiol. 2011;81(10):2801–4.

    Article  PubMed  Google Scholar 

  4. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol. 2003;60:989–94.

    Article  PubMed  Google Scholar 

  5. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–88.

    Article  CAS  PubMed  Google Scholar 

  6. Thies W, Bleiler L. 2011 Alzheimer’s disease facts and figures. Alzheimers Dement. 2011;7:208–44.

    Article  PubMed  Google Scholar 

  7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 1994.

    Google Scholar 

  8. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–22.

    Article  PubMed  Google Scholar 

  9. Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256:184–5.

    Article  CAS  PubMed  Google Scholar 

  10. Swerdlow RH. Brain aging, Alzheimer’s disease, and mitochondria. Biochim Biophys Acta. 1812;2011:1630–9.

    Google Scholar 

  11. Swerdlow RH, Burns JM, Khan SM. The Alzheimer’s disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim Biophys Acta. 2013.

    Google Scholar 

  12. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–81.

    Article  CAS  PubMed  Google Scholar 

  13. Burns JM, Cronk BB, Anderson HS, et al. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008;71:210–6.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.

    Article  PubMed  Google Scholar 

  15. Kuchel GA, Moscufo N, Guttmann CR, et al. Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2009;64:902–9.

    Article  PubMed  Google Scholar 

  16. Black SE. Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management. J R Coll Physicians Edinb. 2011;41:49–56.

    Article  CAS  PubMed  Google Scholar 

  17. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.

    Article  PubMed  Google Scholar 

  18. Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc. 1999;47:564–9.

    CAS  PubMed  Google Scholar 

  19. Mollenhauer B, Forstl H, Deuschl G, Storch A, Oertel W, Trenkwalder C. Lewy body and Parkinsonian dementia: common, but often misdiagnosed conditions. Dtsch Arztebl Int. 2010;107:684–91.

    PubMed Central  PubMed  Google Scholar 

  20. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. 2005. pp. 1863–1872.

    Google Scholar 

  21. Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol. 2003;2:229–37.

    Article  CAS  PubMed  Google Scholar 

  22. Bostrom F, Jonsson L, Minthon L, Londos E. Patients with Lewy body dementia use more resources than those with Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22:713–9.

    Article  PubMed  Google Scholar 

  23. Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007;68:812–9.

    Article  CAS  PubMed  Google Scholar 

  24. Aarsland D, Ballard C, Walker Z, et al. Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2009;8:613–8.

    Article  CAS  PubMed  Google Scholar 

  25. Pasquier F, Delacourte A. Non-Alzheimer degenerative dementias. Curr Opin Neurol. 1998;11:417–27.

    Article  CAS  PubMed  Google Scholar 

  26. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994;57:416–8.

    Article  Google Scholar 

  27. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–21.

    Article  CAS  PubMed  Google Scholar 

  28. Wittenberg D, Possin KL, Rascovsky K, Rankin KP, Miller BL, Kramer JH. The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev. 2008;18:91–102.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.

    Article  CAS  PubMed  Google Scholar 

  30. Mendez MF, Lauterbach EC, Sampson SM. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci. 2008;20:130–49.

    Article  PubMed  Google Scholar 

  31. Cardarelli R, Kertesz A, Knebl JA. Frontotemporal dementia: a review for primary care physicians. Am Fam Physician. 2010;82:1372–7.

    PubMed  Google Scholar 

  32. Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007;15:84–7.

    Article  PubMed  Google Scholar 

  33. Johnson RT. Prion diseases. Lancet Neurol. 2005;4:635–42.

    Article  CAS  PubMed  Google Scholar 

  34. Brown P, Gibbs Jr CJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;35:513–29.

    Article  CAS  PubMed  Google Scholar 

  35. Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79. I: Clinical features. J Neurol Neurosurg Psychiatry. 1984;47:134–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Johnson RT, Gibbs Jr CJ. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med. 1998;339:1994–2004.

    Article  CAS  PubMed  Google Scholar 

  37. Bernoulli CC, Masters CL, Gajdusek DC, Gibbs Jr CJ, Harris JO. Early clinical features of Creutzfeldt-Jakob disease (subacute spongiform encephalopathy). In: Prusiner SB, Hadlow WJ, editors. Slow transmissible diseases of the nervous system. New York, NY: Academic; 1979. p. 229–41.

    Google Scholar 

  38. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76:1711–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med. 1965;273:117–26.

    Article  CAS  PubMed  Google Scholar 

  40. Petersen RC, Mokri B, Laws Jr ER. Surgical treatment of idiopathic hydrocephalus in elderly patients. Neurology. 1985;35:307–11.

    Article  CAS  PubMed  Google Scholar 

  41. Brean A, Eide PK. Prevalence of probable idiopathic normal pressure hydrocephalus in a Norwegian population. Acta Neurol Scand. 2008;118:48–53.

    Article  CAS  PubMed  Google Scholar 

  42. Tanaka N, Yamaguchi S, Ishikawa H, Ishii H, Meguro K. Prevalence of possible idiopathic normal-pressure hydrocephalus in Japan: the Osaki-Tajiri project. Neuroepidemiology. 2009;32:171–5.

    Article  PubMed  Google Scholar 

  43. Hiraoka K, Meguro K, Mori E. Prevalence of idiopathic normal-pressure hydrocephalus in the elderly population of a Japanese rural community. Neurol Med Chir (Tokyo). 2008;48:197–9. discussion 199-200.

    Article  Google Scholar 

  44. Marmarou A, Young HF, Aygok GA. Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities. Neurosurg Focus. 2007;22:E1.

    Google Scholar 

  45. Akiguchi I, Ishii M, Watanabe Y, et al. Shunt-responsive Parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol. 2008;255:1392–9.

    Article  PubMed  Google Scholar 

  46. Klassen BT, Ahlskog JE. Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology. 2011;77:1119–25.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Iverson DJ, Gronseth GS, Reger MA, Classen S, Dubinsky RM, Rizzo M. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:1316–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Young J, Inouye SK. Delirium in older people. BMJ. 2007;334:842–6.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35:350–64.

    Article  PubMed  Google Scholar 

  50. McCusker J, Cole M, Dendukuri N, Han L, Belzile E. The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med. 2003;18:696–704.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Inouye SK. Delirium in older persons. N Engl J Med. 2006;354:1157–65.

    Article  CAS  PubMed  Google Scholar 

  52. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–8.

    Article  CAS  PubMed  Google Scholar 

  53. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58:249–65.

    Article  PubMed  Google Scholar 

  54. Seitz D, Purandare N, Conn D. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr. 2010;22:1025–39.

    Article  PubMed  Google Scholar 

  55. Palsson S, Skoog I. The epidemiology of affective disorders in the elderly: a review. Int Clin Psychopharmacol. 1997;12 Suppl 7:S3–13.

    Article  PubMed  Google Scholar 

  56. Martin LM, Fleming KC, Evans JM. Recognition and management of anxiety and depression in elderly patients. Mayo Clin Proc. 1995;70:999–1006.

    Article  CAS  PubMed  Google Scholar 

  57. Wang J, Williams J, Lavorato D, Schmitz N, Dewa C, Patten SB. The incidence of major depression in Canada: the National Population Health Survey. J Affect Disord. 2010;123:158–63.

    Article  PubMed  Google Scholar 

  58. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64:492–8.

    Article  PubMed  Google Scholar 

  59. Ng TP, Niti M, Zaw MH, Kua EH. Depressive symptoms and incident cognitive impairment in cognitively well-functioning older men and women. J Am Geriatr Soc. 2009;57:1058–63.

    Article  PubMed  Google Scholar 

  60. Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol. 2003;60:1394–9.

    Article  PubMed  Google Scholar 

  61. Waern M, Rubenowitz E, Wilhelmson K. Predictors of suicide in the old elderly. Gerontology. 2003;49:328–34.

    Article  PubMed  Google Scholar 

  62. National Center for Injury Prevention and Control. United States suicide injury deaths and rates per 100,000. 1999–2002. http://www.cdc.gov/ncipc/wisqars/. Accessed 14 May 2008.

  63. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80:90–6.

    Article  PubMed  Google Scholar 

  64. Pintarelli VL, Perchon LF, Lorenzetti F, Toniolo Neto J, Dambros M. Elderly men’s quality of life and lower urinary tract symptoms: an intricate relationship. Int Braz J Urol. 2011;37:758–65.

    Article  PubMed  Google Scholar 

  65. Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA. Nocturia associated with depressive symptoms. Urology. 2011;77:183–6.

    Article  PubMed  Google Scholar 

  66. Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR. Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol. 2012;61:88–95.

    Article  PubMed  Google Scholar 

  67. Losada A, Marquez-Gonzalez M, Garcia-Ortiz L, Gomez-Marcos MA, Fernandez-Fernandez V, Rodriguez-Sanchez E. Loneliness and mental health in a representative sample of community-dwelling Spanish older adults. J Psychol. 2012;146:277–92.

    Article  PubMed  Google Scholar 

  68. Zorn BH, Montgomery H, Pieper K, Gray M, Steers WD. Urinary incontinence and depression. J Urol. 1999;162:82–4.

    Article  CAS  PubMed  Google Scholar 

  69. Segrin C, Badger TA, Figueredo AJ. Stage of disease progression moderates the association between social support and depression in prostate cancer survivors. J Psychosoc Oncol. 2011;29:552–60.

    Article  PubMed  Google Scholar 

  70. Hedgepeth RC, Gilbert SM, He C, Lee CT, Wood Jr DP. Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology. 2010;76:671–5.

    Article  PubMed  Google Scholar 

  71. Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med. 2012;9:1497–507.

    Article  PubMed  Google Scholar 

  72. Sheikh J, Yesavage J. Geriatric depression scale (GDS): recent evidence and development of a shorter version. In: Clinical gerontology: a guide to assessment and intervention. New York, NY: The Hawthorne Press; 1986. p. 165–73.

    Google Scholar 

  73. Tew Jr JD, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry. 1999;156:1865–70.

    PubMed  Google Scholar 

  74. Boyce RD, Hanlon JT, Karp JF, Kloke J, Saleh A, Handler SM. A review of the effectiveness of antidepressant medications for depressed nursing home residents. J Am Med Dir Assoc. 2011;13(4):326–31.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Cuijpers P, Dekker J, Hollon SD, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry. 2009;70:1219–29.

    Article  PubMed  Google Scholar 

  76. GRS. Geriatrics review syllabus: a core curriculum in geriatric medicine. 6th ed. New York, NY: The American Geriatrics Society; 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heather S. Anderson M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Anderson, H.S. (2014). Dementia, Delirium, and Depression. In: Griebling, T. (eds) Geriatric Urology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9047-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9047-0_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9046-3

  • Online ISBN: 978-1-4614-9047-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics